Literature DB >> 34039534

Monitoring Behaviors of Patients With Late-Stage Dementia Using Passive Environmental Sensing Approaches: A Case Series.

Wan-Tai M Au-Yeung1, Lyndsey Miller2, Zachary Beattie3, Rose May4, Hailey V Cray4, Zachary Kabelac5, Dina Katabi5, Jeffrey Kaye3, Ipsit V Vahia6.   

Abstract

OBJECTIVE: To show the feasibility of using different unobtrusive activity-sensing technologies to provide objective behavioral markers of persons with dementia (PwD).
DESIGN: Monitored the behaviors of two PwD living in memory care unit using the Oregon Center for Aging & Technology (ORCATECH) platform, and the behaviors of two PwD living in assisted living facility using the Emerald device.
SETTING: A memory care unit in Portland, Oregon and an assisted living facility in Framingham, Massachusetts. PARTICIPANTS: A 63-year-old male with Alzheimer's disease (AD), and an 80-year-old female with frontotemporal dementia, both lived in a memory care unit in Portland, Oregon. An 89-year-old woman with a diagnosis of AD, and an 85-year-old woman with a diagnosis of major neurocognitive disorder, Alzheimer's type with behavioral symptoms, both resided at an assisted living facility in Framingham, Massachusetts. MEASUREMENTS: These include: sleep quality measured by the bed pressure mat; number of transitions between spaces and dwell times in different spaces measured by the motion sensors; activity levels measured by the wearable actigraphy device; and couch usage and limb movements measured by the Emerald device.
RESULTS: Number of transitions between spaces can identify the patient's episodes of agitation; activity levels correlate well with the patient's excessive level of agitation and lack of movement when the patient received potentially inappropriate medication and neared the end of life; couch usage can detect the patient's increased level of apathy; and periodic limb movements can help detect risperidone-induced side effects. This is the first demonstration that the ORCATECH platform and the Emerald device can measure such activities.
CONCLUSION: The use of technologies for monitoring behaviors of PwD can provide more objective and intensive measurements of PwD behaviors.
Copyright © 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Unobtrusive activity-sensing technology; agitation; apathy; behavioral and psychological symptoms; end-of-life; late-stage dementia; potentially inappropriate medication; technology

Mesh:

Year:  2021        PMID: 34039534      PMCID: PMC8531172          DOI: 10.1016/j.jagp.2021.04.008

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  31 in total

1.  Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments.

Authors:  M Margallo-Lana; A Swann; J O'Brien; A Fairbairn; K Reichelt; D Potkins; P Mynt; C Ballard
Journal:  Int J Geriatr Psychiatry       Date:  2001-01       Impact factor: 3.485

2.  Sources of discomfort in persons with dementia.

Authors:  Jiska Cohen-Mansfield; Khin Thein; Marcia S Marx; Maha Dakheel-Ali; Barbara Jensen
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

Review 3.  Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: development of practice recommendations in a Swiss canton.

Authors:  Jean-François Locca; Christophe J Büla; Serge Zumbach; Oliver Bugnon
Journal:  J Am Med Dir Assoc       Date:  2008-07       Impact factor: 4.669

4.  Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data.

Authors:  Jeffrey Kaye; Christina Reynolds; Molly Bowman; Nicole Sharma; Thomas Riley; Ona Golonka; Jonathan Lee; Charlie Quinn; Zachary Beattie; Johanna Austin; Adriana Seelye; Katherine Wild; Nora Mattek
Journal:  J Vis Exp       Date:  2018-07-27       Impact factor: 1.355

Review 5.  Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials.

Authors:  Gill Livingston; Lynsey Kelly; Elanor Lewis-Holmes; Gianluca Baio; Stephen Morris; Nishma Patel; Rumana Z Omar; Cornelius Katona; Claudia Cooper
Journal:  Br J Psychiatry       Date:  2014-12       Impact factor: 9.319

6.  Agitation in dementia and the role of spatial and sensory interventions: experiences of professional and family caregivers.

Authors:  Marieke Van Vracem; Nele Spruytte; Anja Declercq; Chantal Van Audenhove
Journal:  Scand J Caring Sci       Date:  2015-05-11

Review 7.  Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument.

Authors:  J Cohen-Mansfield
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

8.  Radio Signal Sensing and Signal Processing to Monitor Behavioral Symptoms in Dementia: A Case Study.

Authors:  Ipsit V Vahia; Zachary Kabelac; Chen-Yu Hsu; Brent P Forester; Patrick Monette; Rose May; Katherine Hobbs; Usman Munir; Kreshnik Hoti; Dina Katabi
Journal:  Am J Geriatr Psychiatry       Date:  2020-03-08       Impact factor: 4.105

Review 9.  Assessment and management of behavioral and psychological symptoms of dementia.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  BMJ       Date:  2015-03-02

10.  Long-Term Pain Treatment Did Not Improve Sleep in Nursing Home Patients with Comorbid Dementia and Depression: A 13-Week Randomized Placebo-Controlled Trial.

Authors:  Kjersti M Blytt; Bettina Husebo; Elisabeth Flo; Bjørn Bjorvatn
Journal:  Front Psychol       Date:  2018-02-13
View more
  4 in total

1.  Digital Dementia Care for the Future: Opportunities and Challenges.

Authors:  Marina Ramsey; Ellen E Lee
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-16       Impact factor: 4.105

Review 2.  Affective Computing for Late-Life Mood and Cognitive Disorders.

Authors:  Erin Smith; Eric A Storch; Ipsit Vahia; Stephen T C Wong; Helen Lavretsky; Jeffrey L Cummings; Harris A Eyre
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

3.  Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia.

Authors:  Nergis C Khan; Vineet Pandey; Krzysztof Z Gajos; Anoopum S Gupta
Journal:  Cerebellum       Date:  2021-07-24       Impact factor: 3.648

4.  The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2.

Authors:  Benjamin Harris Peterson Corman; Sritha Rajupet; Fan Ye; Elinor Randi Schoenfeld
Journal:  J Med Internet Res       Date:  2022-01-26       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.